1
|
Chawanpaiboon S, Vogel JP, Moller AB,
Lumbiganon P, Petzold M, Hogan D, Landoulsi S, Jampathong N,
Kongwattanakul K, Laopaiboon M, et al: 2019.Global, regional, and
national estimates of levels of preterm birth in 2014: A systematic
review and modelling analysis. Lancet Glob Health. 7:e37–e46. 2019.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Stoll BJ, Hansen NI, Bell EF, Walsh MC,
Carlo WA, Shankaran S, Laptook AR, Sánchez PJ, Van Meurs KP,
Wyckoff M, et al: Trends in care practices, morbidity, and
mortality of extremely preterm neonates, 1993–2012. JAMA.
314:1039–1051. 2015. View Article : Google Scholar : PubMed/NCBI
|
3
|
Cao Y, Jiang S, Sun J, Hei M, Wang L,
Zhang H, Ma X, Wu H, Li X, Sun H, et al: Assessment of Neonatal
Intensive care unit practices, morbidity, and mortality among very
preterm infants in China. JAMA Netw Open. 4:e21189042021.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Zhu Z, Yuan L, Wang J, Li Q, Yang C, Gao
X, Chen S, Han S, Liu J, Wu H, et al: Mortality and morbidity of
infants born extremely preterm at tertiary medical centers in China
from 2010 to 2019. JAMA Netw Open. 4:e2193822021. View Article : Google Scholar : PubMed/NCBI
|
5
|
Gilfillan M, Bhandari A and Bhandari V:
Diagnosis and management of bronchopulmonary dysplasia. BMJ.
375:n19742021. View Article : Google Scholar : PubMed/NCBI
|
6
|
Thébaud B, Goss KN, Laughon M, Whitsett
JA, Abman SH, Steinhorn RH, Aschner JL, Davis PG, McGrath-Morrow
SA, Soll RF and Jobe AH: Bronchopulmonary dysplasia. Nat Rev Dis
Primers. 5:782019. View Article : Google Scholar : PubMed/NCBI
|
7
|
Papagianis PC, Pillow JJ and Moss TJ:
Bronchopulmonary dysplasia: Pathophysiology and potential
anti-inflammatory therapies. Paediatr Respir Rev. 30:34–41.
2019.PubMed/NCBI
|
8
|
Savani RC: Modulators of inflammation in
Bronchopulmonary Dysplasia. Semin Perinatol. 42:459–470. 2018.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Surate Solaligue DE, Rodríguez-Castillo
JA, Ahlbrecht K and Morty RE: Recent advances in our understanding
of the mechanisms of late lung development and bronchopulmonary
dysplasia. Am J Physiol Lung Cell Mol Physiol. 313:L1101–L1153.
2017. View Article : Google Scholar : PubMed/NCBI
|
10
|
Augustine S, Avey MT, Harrison B, Locke T,
Ghannad M, Moher D and Thébaud B: Mesenchymal stromal cell therapy
in bronchopulmonary dysplasia: Systematic review and Meta-Analysis
of preclinical studies. Stem Cells Transl Med. 6:2079–2093. 2017.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Walter J, Ware LB and Matthay MA:
Mesenchymal stem cells: Mechanisms of potential therapeutic benefit
in ARDS and sepsis. Lancet Respir Med. 2:1016–1026. 2014.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Nitkin CR, Rajasingh J, Pisano C, Besner
GE, Thébaud B and Sampath V: Stem cell therapy for preventing
neonatal diseases in the 21st century: Current understanding and
challenges. Pediatr Res. 87:265–276. 2020. View Article : Google Scholar : PubMed/NCBI
|
13
|
Zhuxiao R, Fang X, Wei W, Shumei Y,
Jianlan W, Qiuping L, Jingjun P, Chuan N, Yongsheng L, Zhichun F
and Jie Y: Prevention for moderate or severe BPD with intravenous
infusion of autologous cord blood mononuclear cells in very preterm
infants-a prospective non-randomized placebo-controlled trial and
two-year follow up outcomes. EClinicalMedicine. 57:1018442023.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Carbone C, Piro G, Merz V, Simionato F,
Santoro R, Zecchetto C, Tortora G and Melisi D: Angiopoietin-Like
proteins in angiogenesis, inflammation and cancer. Int J Mol Sci.
19:4312018. View Article : Google Scholar : PubMed/NCBI
|
15
|
Xiao Y, Jiang Z, Li Y, Ye W, Jia B, Zhang
M, Xu Y, Wu D, Lai L, Chen Y, et al: ANGPTL7 regulates the
expansion and repopulation of human hematopoietic stem and
progenitor cells. Haematologica. 100:585–594. 2015. View Article : Google Scholar : PubMed/NCBI
|
16
|
Xiao Y, Wei X, Jiang Z, Wang X, Ye W, Liu
X, Zhang M, Xu Y, Wu D, Lai L, et al: Loss of Angiopoietin-like 7
diminishes the regeneration capacity of hematopoietic stem and
progenitor cells. J Hematol Oncol. 8:72015. View Article : Google Scholar : PubMed/NCBI
|
17
|
Parri M, Pietrovito L, Grandi A,
Campagnoli S, De Camilli E, Bianchini F, Marchiò S, Bussolino F,
Jin B, Sarmientos P, et al: Angiopoietin-like 7, a novel
pro-angiogenetic factor over-expressed in cancer. Angiogenesis.
17:881–896. 2014. View Article : Google Scholar : PubMed/NCBI
|
18
|
Xia X, Ren Z, Yan L, Zheng X, Yang H, Kang
M, Yan H, Zhong Z, Xu F, Miao J, et al: Cord blood levels of
Angiopoietin-like 7 (Angptl7) in preterm infants. Biomed Res Int.
2020:18924582020. View Article : Google Scholar : PubMed/NCBI
|
19
|
Gomella TL, Cunningham MD and Eyal F:
Neonatology. 7th edition. New York: McGraw-Hill Education; 2013
|
20
|
Gary Cunningham F, Leveno KJ and Bloom S:
Williams Obstetrics. 25th edition. New York: McGraw-Hill Education;
2018
|
21
|
Jobe AH and Bancalari E: Bronchopulmonary
dysplasia. Am J Respir Crit Care. 163:1723–1729. 2001. View Article : Google Scholar : PubMed/NCBI
|
22
|
Ren Z, Xu F, Wang J, Zhong Z, Wei W, Wen
J, Wang Q, Guocheng L and Yang J: Safety and feasibility of
umbilical cord blood collection from preterm neonates after delayed
cord clamping for the use of improving preterm complications. Am J
Transl Res. 13:4553–4560. 2021.PubMed/NCBI
|
23
|
Ren Z, Mo W, Yang L, Wang J, Zhang Q,
Zhong Z, Wei W, Liu Z, Wu Z, Yao Y and Yang J: Cord blood
antimicrobial peptide LL37 levels in preterm neonates and
association with preterm complications. Ital J Pediatr. 48:1112022.
View Article : Google Scholar : PubMed/NCBI
|
24
|
National Research Council (US) Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals, . Guide for the Care and Use of Laboratory Animals. 8th
edition. Washington (DC); National Academies Press (US): 2011
|
25
|
Berger J and Bhandari V: Animal models of
bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol.
307:L936–L947. 2014. View Article : Google Scholar : PubMed/NCBI
|
26
|
Shrestha AK, Bettini ML, Menon RT, Gopal
VYN, Huang S, Edwards DP, Pammi M, Barrios R and Shivanna B:
Consequences of early postnatal lipopolysaccharide exposure on
developing lungs in mice. Am J Physiol Lung Cell Mol Physiol.
316:L229–L244. 2019. View Article : Google Scholar : PubMed/NCBI
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Baker CD and Abman SH: Impaired pulmonary
vascular development in bronchopulmonary dysplasia. Neonatology.
107:344–351. 2015. View Article : Google Scholar : PubMed/NCBI
|
29
|
Chang DV, Assaf SJ, Tiller CJ, Kisling JA
and Tepper RS: Membrane and capillary components of lung diffusion
in infants with bronchopulmonary dysplasia. Am J Respir Crit Care
Med. 193:767–771. 2016. View Article : Google Scholar : PubMed/NCBI
|
30
|
Alvira CM: Aberrant pulmonary vascular
growth and remodeling in bronchopulmonary dysplasia. Front Med
(Lausanne). 3:212016.PubMed/NCBI
|
31
|
Arora S, Dev K, Agarwal B, Das P and Syed
MA: Macrophages: Their role, activation and polarization in
pulmonary diseases. Immunobiology. 223:383–396. 2018. View Article : Google Scholar : PubMed/NCBI
|
32
|
Behnke J, Kremer S, Shahzad T, Chao CM,
Böttcher-Friebertshäuser E, Morty RE, Bellusci S and Ehrhardt H:
MSC based therapies-new perspectives for the injured lung. J Clin
Med. 9:6822020. View Article : Google Scholar : PubMed/NCBI
|
33
|
Matthay MA, Calfee CS, Zhuo H, Thompson
BT, Wilson JG, Levitt JE, Rogers AJ, Gotts JE, Wiener-Kronish JP,
Bajwa EK, et al: Treatment with allogeneic mesenchymal stromal
cells for moderate to severe acute respiratory distress syndrome
(START study): A randomised phase 2a safety trial. Lancet Respir
Med. 7:154–162. 2019. View Article : Google Scholar : PubMed/NCBI
|
34
|
Nitkin CR, Rajasingh J, Pisano C, Besner
GE, Thébaud B and Sampath V: Stem cell therapy for preventing
neonatal diseases in the 21st century: Current understanding and
challenges. Pediatr Res. 87:265–276. 2020. View Article : Google Scholar : PubMed/NCBI
|
35
|
Chang YS, Ahn SY, Yoo HS, Sung SI, Choi
SJ, Oh WI and Park WS: Mesenchymal stem cells for bronchopulmonary
dysplasia: Phase 1 dose-escalation clinical trial. J Pediatr.
164:966–972.e6. 2014. View Article : Google Scholar : PubMed/NCBI
|
36
|
Powell SB and Silvestri JM: Safety of
intratracheal administration of human umbilical cord blood derived
mesenchymal stromal cells in extremely low birth weight preterm
infants. J Pediatr. 210:209–213.e2. 2019. View Article : Google Scholar : PubMed/NCBI
|
37
|
Carbone C, Piro G, Merz V, Simionato F,
Santoro R, Zecchetto C, Tortora G and Melisi D: Angiopoietin-like
proteins in angiogenesis, inflammation and cancer. Int J Mol Sci.
19:4312018. View Article : Google Scholar : PubMed/NCBI
|
38
|
Qian T, Wang K, Cui J, He Y and Yang Z:
Angiopoietin-like protein 7 promotes an inflammatory phenotype in
RAW264.7 macrophages through the P38 MAPK signaling pathway.
Inflammation. 39:974–985. 2016.PubMed/NCBI
|
39
|
Zhao Y, Liu K, Yin D and Lin Z:
Angiopoietin-Like 7 contributes to angiotensin ii-induced
proliferation, inflammation and apoptosis in vascular smooth muscle
cells. Pharmacology. 104:226–234. 2019. View Article : Google Scholar : PubMed/NCBI
|
40
|
Zepp JA and Morrisey EE: Cellular
crosstalk in the development and regeneration of the respiratory
system. Nat Rev Mol Cell Biol. 20:551–566. 2019. View Article : Google Scholar : PubMed/NCBI
|
41
|
Cui TX, Brady AE, Fulton CT, Zhang YJ,
Rosenbloom LM, Goldsmith AM, Moore BB and Popova AP: CCR2 mediates
chronic LPS-induced pulmonary inflammation and hypoalveolarization
in a murine model of bronchopulmonary dysplasia. Front Immunol.
11:5796282020. View Article : Google Scholar : PubMed/NCBI
|
42
|
Shrestha AK, Menon RT, El-Saie A, Barrios
R, Reynolds C and Shivanna B: Interactive and independent effects
of early lipopolysaccharide and hyperoxia exposure on developing
murine lungs. Am J Physiol Lung Cell Mol Physiol. 319:L981–L996.
2020. View Article : Google Scholar : PubMed/NCBI
|
43
|
Toyono T, Usui T, Yokoo S, Taketani Y,
Nakagawa S, Kuroda M, Yamagami S and Amano S: Angiopoietin-like 7
is an anti-angiogenic protein required to prevent vascularization
of the cornea. PLoS One. 10:e01168382015. View Article : Google Scholar : PubMed/NCBI
|
44
|
Lu X, Lu J, Zhang L and Xu Y: Effect of
Angptl7 on proliferation and differentiation of MC3T3-E1 cells. Med
Sci Monit. 25:9524–9530. 2019. View Article : Google Scholar : PubMed/NCBI
|
45
|
Kandasamy J, Olave N, Ballinger SW and
Ambalavanan N: Vascular endothelial mitochondrial function predicts
death or pulmonary outcomes in preterm infants. Am J Respir Crit
Care Med. 196:1040–1049. 2017. View Article : Google Scholar : PubMed/NCBI
|
46
|
Speer CP: Inflammation and
bronchopulmonary dysplasia: A continuing story. Semin Fetal
Neonatal Med. 11:354–362. 2006. View Article : Google Scholar : PubMed/NCBI
|
47
|
Sahni M and Bhandari V: Recent advances in
understanding and management of bronchopulmonary dysplasia.
F1000Res. 9:F1000Faculty Rev 703, 2020. PubMed/NCBI
|
48
|
Lu X, Gong J, Dennery PA and Yao H:
Endothelial-to-mesenchymal transition: Pathogenesis and therapeutic
targets for chronic pulmonary and vascular diseases. Biochem
Pharmacol. 168:100–107. 2019. View Article : Google Scholar : PubMed/NCBI
|
49
|
Tammela T, Enholm B, Alitalo K and
Paavonen K: The biology of vascular endothelial growth factors.
Cardiovasc Res. 65:550–563. 2005. View Article : Google Scholar : PubMed/NCBI
|
50
|
Mariduena J, Ramagopal M, Hiatt M, Chandra
S, Laumbach R and Hegyi T: Vascular endothelial growth factor
levels and bronchopulmonary dysplasia in preterm infants. J Matern
Fetal Neonatal Med. 35:1517–1522. 2022. View Article : Google Scholar : PubMed/NCBI
|
51
|
Hendricks-Muñoz KD, Xu J and Voynow JA:
Tracheal aspirate VEGF and sphingolipid metabolites in the preterm
infant with later development of bronchopulmonary dysplasia.
Pediatr Pulmonol. 53:1046–1052. 2018. View Article : Google Scholar : PubMed/NCBI
|